Velan Capital Investment Management »

Maplight Therapeutics shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.2M 522k 17.57

More positions owned by Velan Capital Investment Management

Praxis Precision Medicines I Com New (PRAX)
Cidara Therapeutics Com New (CDTX)
Protara Therapeutics Com Stk (TARA)
Heron Therapeutics (HRTX)
Maplight Therapeutics (MPLT)
Abivax Sa Sponsored Ads (ABVX)
Evommune Com Shs (EVMN)
Mineralys Therapeutics (MLYS)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Jasper Therapeutics Com New (JSPR)
Avalo Therapeutics Com New (AVTX)
Esperion Therapeutics (ESPR)
Verrica Pharmaceuticals Com Shs (VRCA)
Inspiremd (NSPR)
Rapt Therapeutics Com New (RAPT)

View all positions for Velan Capital Investment Management

Top funds holding Maplight Therapeutics

Novo A/S
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Velan Capital Investment Management
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners
Polygon Management

View all funds holding Maplight Therapeutics